Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma.
about
Current strategies for salvage treatment for relapsed classical Hodgkin lymphoma.Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study.Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group
P2860
Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@ast
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@en
type
label
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@ast
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@en
prefLabel
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@ast
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@en
P2093
P2860
P356
P1476
Gemcitabine and oxaliplatinum: ...... nd relapsing Hodgkin lymphoma.
@en
P2093
Andres Novo
Antonia Sampol
Antonio Gutierrez
Florencia Garcia
Javier Vercher
Joan Bargay
Joan Besalduch
Jordi Gines
Jordi Martinez-Serra
Jose Rodriguez
P2860
P304
P356
10.2147/OTT.S70264
P407
P50
P577
2014-11-13T00:00:00Z